ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Genito-Urinary Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-14C12252
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Genito Urinary Drugs Industry Research Report Growth Trends and Competitive Analysis 2022 2028
BUY CHAPTERS

Genito-Urinary Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-14C12252
Report
September 2024
Pages:95
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Daiichi Sankyo Company
Pfizer Inc
Bayer
Astellas Pharma
GSK
Otsuka Pharmaceutical
Sanofi
AbbVie

Genito-Urinary Drugs - Market Size

The global market for Genito-Urinary Drugs was estimated to be worth US$ 28510 million in 2023 and is forecast to a readjusted size of US$ 35930 million by 2030 with a CAGR of 3.3% during the forecast period 2024-2030

Genito-Urinary Drugs - Market

Genito-Urinary Drugs - Market

Antibiotic drugs are the basis of urinary tract infection treatment. Antibiotic treatment involves determining the type of bacteria present and choosing the appropriate drug. Antibacterials for urine infections include nalidixic acid, nitrofurantoin, ofloxacin and norfloxacin (for complicated urinary tract infections).
The Genito-Urinary Drugs market refers to the pharmaceuticals and medications used for the treatment of disorders and diseases related to the genitourinary system, which includes the reproductive organs and the urinary tract. This market encompasses various therapeutic areas such as erectile dysfunction, urinary incontinence, urinary tract infections, and prostate disorders. The Genito-Urinary Drugs market has been witnessing steady growth in recent years due to factors such as the increasing prevalence of genitourinary disorders, rising awareness about available treatment options, and advancements in drug development. Additionally, the aging population and changing lifestyle patterns have contributed to the market's expansion.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Genito-Urinary Drugs, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Genito-Urinary Drugs by region & country, by Type, and by Application.
The Genito-Urinary Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genito-Urinary Drugs.
Market Segmentation

Scope of Genito-Urinary Drugs - Market Report

Report Metric Details
Report Name Genito-Urinary Drugs - Market
Forecasted market size in 2030 US$ 35930 million
CAGR 3.3%
Forecasted years 2024 - 2030
Segment by Type:
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Daiichi Sankyo Company, Pfizer, Bayer, Astellas Pharma, AbbVie, GSK, Otsuka Pharmaceutical, Sanofi
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Genito-Urinary Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Genito-Urinary Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Genito-Urinary Drugs in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Genito-Urinary Drugs - Market size in 2030?

Ans: The Genito-Urinary Drugs - Market size in 2030 will be US$ 35930 million.

Who are the main players in the Genito-Urinary Drugs - Market report?

Ans: The main players in the Genito-Urinary Drugs - Market are Daiichi Sankyo Company, Pfizer, Bayer, Astellas Pharma, AbbVie, GSK, Otsuka Pharmaceutical, Sanofi

What are the Application segmentation covered in the Genito-Urinary Drugs - Market report?

Ans: The Applications covered in the Genito-Urinary Drugs - Market report are Hospital, Drugs Store, Other

What are the Type segmentation covered in the Genito-Urinary Drugs - Market report?

Ans: The Types covered in the Genito-Urinary Drugs - Market report are OTC, Rx Drugs

Recommended Reports

Urological Disorders

Reproductive Health

Prostate & BPH

1 Market Overview
1.1 Genito-Urinary Drugs Product Introduction
1.2 Global Genito-Urinary Drugs Market Size Forecast
1.2.1 Global Genito-Urinary Drugs Sales Value (2019-2030)
1.2.2 Global Genito-Urinary Drugs Sales Volume (2019-2030)
1.2.3 Global Genito-Urinary Drugs Sales Price (2019-2030)
1.3 Genito-Urinary Drugs Market Trends & Drivers
1.3.1 Genito-Urinary Drugs Industry Trends
1.3.2 Genito-Urinary Drugs Market Drivers & Opportunity
1.3.3 Genito-Urinary Drugs Market Challenges
1.3.4 Genito-Urinary Drugs Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Genito-Urinary Drugs Players Revenue Ranking (2023)
2.2 Global Genito-Urinary Drugs Revenue by Company (2019-2024)
2.3 Global Genito-Urinary Drugs Players Sales Volume Ranking (2023)
2.4 Global Genito-Urinary Drugs Sales Volume by Company Players (2019-2024)
2.5 Global Genito-Urinary Drugs Average Price by Company (2019-2024)
2.6 Key Manufacturers Genito-Urinary Drugs Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Genito-Urinary Drugs Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Genito-Urinary Drugs
2.9 Genito-Urinary Drugs Market Competitive Analysis
2.9.1 Genito-Urinary Drugs Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Genito-Urinary Drugs Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genito-Urinary Drugs as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 OTC
3.1.2 Rx Drugs
3.2 Global Genito-Urinary Drugs Sales Value by Type
3.2.1 Global Genito-Urinary Drugs Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Genito-Urinary Drugs Sales Value, by Type (2019-2030)
3.2.3 Global Genito-Urinary Drugs Sales Value, by Type (%) (2019-2030)
3.3 Global Genito-Urinary Drugs Sales Volume by Type
3.3.1 Global Genito-Urinary Drugs Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Genito-Urinary Drugs Sales Volume, by Type (2019-2030)
3.3.3 Global Genito-Urinary Drugs Sales Volume, by Type (%) (2019-2030)
3.4 Global Genito-Urinary Drugs Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Drugs Store
4.1.3 Other
4.2 Global Genito-Urinary Drugs Sales Value by Application
4.2.1 Global Genito-Urinary Drugs Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Genito-Urinary Drugs Sales Value, by Application (2019-2030)
4.2.3 Global Genito-Urinary Drugs Sales Value, by Application (%) (2019-2030)
4.3 Global Genito-Urinary Drugs Sales Volume by Application
4.3.1 Global Genito-Urinary Drugs Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Genito-Urinary Drugs Sales Volume, by Application (2019-2030)
4.3.3 Global Genito-Urinary Drugs Sales Volume, by Application (%) (2019-2030)
4.4 Global Genito-Urinary Drugs Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Genito-Urinary Drugs Sales Value by Region
5.1.1 Global Genito-Urinary Drugs Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Genito-Urinary Drugs Sales Value by Region (2019-2024)
5.1.3 Global Genito-Urinary Drugs Sales Value by Region (2025-2030)
5.1.4 Global Genito-Urinary Drugs Sales Value by Region (%), (2019-2030)
5.2 Global Genito-Urinary Drugs Sales Volume by Region
5.2.1 Global Genito-Urinary Drugs Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Genito-Urinary Drugs Sales Volume by Region (2019-2024)
5.2.3 Global Genito-Urinary Drugs Sales Volume by Region (2025-2030)
5.2.4 Global Genito-Urinary Drugs Sales Volume by Region (%), (2019-2030)
5.3 Global Genito-Urinary Drugs Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Genito-Urinary Drugs Sales Value, 2019-2030
5.4.2 North America Genito-Urinary Drugs Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Genito-Urinary Drugs Sales Value, 2019-2030
5.5.2 Europe Genito-Urinary Drugs Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Genito-Urinary Drugs Sales Value, 2019-2030
5.6.2 Asia Pacific Genito-Urinary Drugs Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Genito-Urinary Drugs Sales Value, 2019-2030
5.7.2 South America Genito-Urinary Drugs Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Genito-Urinary Drugs Sales Value, 2019-2030
5.8.2 Middle East & Africa Genito-Urinary Drugs Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Genito-Urinary Drugs Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Genito-Urinary Drugs Sales Value
6.2.1 Key Countries/Regions Genito-Urinary Drugs Sales Value, 2019-2030
6.2.2 Key Countries/Regions Genito-Urinary Drugs Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Genito-Urinary Drugs Sales Value, 2019-2030
6.3.2 United States Genito-Urinary Drugs Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Genito-Urinary Drugs Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Genito-Urinary Drugs Sales Value, 2019-2030
6.4.2 Europe Genito-Urinary Drugs Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Genito-Urinary Drugs Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Genito-Urinary Drugs Sales Value, 2019-2030
6.5.2 China Genito-Urinary Drugs Sales Value by Type (%), 2023 VS 2030
6.5.3 China Genito-Urinary Drugs Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Genito-Urinary Drugs Sales Value, 2019-2030
6.6.2 Japan Genito-Urinary Drugs Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Genito-Urinary Drugs Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Genito-Urinary Drugs Sales Value, 2019-2030
6.7.2 South Korea Genito-Urinary Drugs Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Genito-Urinary Drugs Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Genito-Urinary Drugs Sales Value, 2019-2030
6.8.2 Southeast Asia Genito-Urinary Drugs Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Genito-Urinary Drugs Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Genito-Urinary Drugs Sales Value, 2019-2030
6.9.2 India Genito-Urinary Drugs Sales Value by Type (%), 2023 VS 2030
6.9.3 India Genito-Urinary Drugs Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Daiichi Sankyo Company
7.1.1 Daiichi Sankyo Company Company Information
7.1.2 Daiichi Sankyo Company Introduction and Business Overview
7.1.3 Daiichi Sankyo Company Genito-Urinary Drugs Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Daiichi Sankyo Company Genito-Urinary Drugs Product Offerings
7.1.5 Daiichi Sankyo Company Recent Development
7.2 Pfizer
7.2.1 Pfizer Company Information
7.2.2 Pfizer Introduction and Business Overview
7.2.3 Pfizer Genito-Urinary Drugs Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Pfizer Genito-Urinary Drugs Product Offerings
7.2.5 Pfizer Recent Development
7.3 Bayer
7.3.1 Bayer Company Information
7.3.2 Bayer Introduction and Business Overview
7.3.3 Bayer Genito-Urinary Drugs Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Bayer Genito-Urinary Drugs Product Offerings
7.3.5 Bayer Recent Development
7.4 Astellas Pharma
7.4.1 Astellas Pharma Company Information
7.4.2 Astellas Pharma Introduction and Business Overview
7.4.3 Astellas Pharma Genito-Urinary Drugs Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Astellas Pharma Genito-Urinary Drugs Product Offerings
7.4.5 Astellas Pharma Recent Development
7.5 AbbVie
7.5.1 AbbVie Company Information
7.5.2 AbbVie Introduction and Business Overview
7.5.3 AbbVie Genito-Urinary Drugs Sales, Revenue and Gross Margin (2019-2024)
7.5.4 AbbVie Genito-Urinary Drugs Product Offerings
7.5.5 AbbVie Recent Development
7.6 GSK
7.6.1 GSK Company Information
7.6.2 GSK Introduction and Business Overview
7.6.3 GSK Genito-Urinary Drugs Sales, Revenue and Gross Margin (2019-2024)
7.6.4 GSK Genito-Urinary Drugs Product Offerings
7.6.5 GSK Recent Development
7.7 Otsuka Pharmaceutical
7.7.1 Otsuka Pharmaceutical Company Information
7.7.2 Otsuka Pharmaceutical Introduction and Business Overview
7.7.3 Otsuka Pharmaceutical Genito-Urinary Drugs Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Otsuka Pharmaceutical Genito-Urinary Drugs Product Offerings
7.7.5 Otsuka Pharmaceutical Recent Development
7.8 Sanofi
7.8.1 Sanofi Company Information
7.8.2 Sanofi Introduction and Business Overview
7.8.3 Sanofi Genito-Urinary Drugs Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Sanofi Genito-Urinary Drugs Product Offerings
7.8.5 Sanofi Recent Development
8 Industry Chain Analysis
8.1 Genito-Urinary Drugs Industrial Chain
8.2 Genito-Urinary Drugs Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Genito-Urinary Drugs Sales Model
8.5.2 Sales Channel
8.5.3 Genito-Urinary Drugs Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
FEATURED COMPANIES
Daiichi Sankyo Company
Pfizer Inc
Bayer
Astellas Pharma
GSK
Otsuka Pharmaceutical
Sanofi
AbbVie
List of Tables
    Table 1. Genito-Urinary Drugs Market Trends
    Table 2. Genito-Urinary Drugs Market Drivers & Opportunity
    Table 3. Genito-Urinary Drugs Market Challenges
    Table 4. Genito-Urinary Drugs Market Restraints
    Table 5. Global Genito-Urinary Drugs Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Genito-Urinary Drugs Revenue Market Share by Company (2019-2024)
    Table 7. Global Genito-Urinary Drugs Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Genito-Urinary Drugs Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Genito-Urinary Drugs Price by Company (2019-2024) & (USD/Unit)
    Table 10. Key Manufacturers Genito-Urinary Drugs Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Genito-Urinary Drugs Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Genito-Urinary Drugs
    Table 13. Global Genito-Urinary Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genito-Urinary Drugs as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Genito-Urinary Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Genito-Urinary Drugs Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Genito-Urinary Drugs Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Genito-Urinary Drugs Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Genito-Urinary Drugs Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Genito-Urinary Drugs Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Genito-Urinary Drugs Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Genito-Urinary Drugs Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Genito-Urinary Drugs Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Genito-Urinary Drugs Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Genito-Urinary Drugs Price by Type (2019-2024) & (USD/Unit)
    Table 27. Global Genito-Urinary Drugs Price by Type (2025-2030) & (USD/Unit)
    Table 28. Global Genito-Urinary Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Genito-Urinary Drugs Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Genito-Urinary Drugs Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Genito-Urinary Drugs Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Genito-Urinary Drugs Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Genito-Urinary Drugs Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Genito-Urinary Drugs Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Genito-Urinary Drugs Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Genito-Urinary Drugs Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Genito-Urinary Drugs Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Genito-Urinary Drugs Price by Application (2019-2024) & (USD/Unit)
    Table 39. Global Genito-Urinary Drugs Price by Application (2025-2030) & (USD/Unit)
    Table 40. Global Genito-Urinary Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Genito-Urinary Drugs Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Genito-Urinary Drugs Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Genito-Urinary Drugs Sales Value by Region (2019-2024) & (%)
    Table 44. Global Genito-Urinary Drugs Sales Value by Region (2025-2030) & (%)
    Table 45. Global Genito-Urinary Drugs Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Genito-Urinary Drugs Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Genito-Urinary Drugs Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Genito-Urinary Drugs Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Genito-Urinary Drugs Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Genito-Urinary Drugs Average Price by Region (2019-2024) & (USD/Unit)
    Table 51. Global Genito-Urinary Drugs Average Price by Region (2025-2030) & (USD/Unit)
    Table 52. Key Countries/Regions Genito-Urinary Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Genito-Urinary Drugs Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Genito-Urinary Drugs Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Genito-Urinary Drugs Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Genito-Urinary Drugs Sales Volume, (2025-2030) & (K Units)
    Table 57. Daiichi Sankyo Company Company Information
    Table 58. Daiichi Sankyo Company Introduction and Business Overview
    Table 59. Daiichi Sankyo Company Genito-Urinary Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 60. Daiichi Sankyo Company Genito-Urinary Drugs Product Offerings
    Table 61. Daiichi Sankyo Company Recent Development
    Table 62. Pfizer Company Information
    Table 63. Pfizer Introduction and Business Overview
    Table 64. Pfizer Genito-Urinary Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 65. Pfizer Genito-Urinary Drugs Product Offerings
    Table 66. Pfizer Recent Development
    Table 67. Bayer Company Information
    Table 68. Bayer Introduction and Business Overview
    Table 69. Bayer Genito-Urinary Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 70. Bayer Genito-Urinary Drugs Product Offerings
    Table 71. Bayer Recent Development
    Table 72. Astellas Pharma Company Information
    Table 73. Astellas Pharma Introduction and Business Overview
    Table 74. Astellas Pharma Genito-Urinary Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 75. Astellas Pharma Genito-Urinary Drugs Product Offerings
    Table 76. Astellas Pharma Recent Development
    Table 77. AbbVie Company Information
    Table 78. AbbVie Introduction and Business Overview
    Table 79. AbbVie Genito-Urinary Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 80. AbbVie Genito-Urinary Drugs Product Offerings
    Table 81. AbbVie Recent Development
    Table 82. GSK Company Information
    Table 83. GSK Introduction and Business Overview
    Table 84. GSK Genito-Urinary Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 85. GSK Genito-Urinary Drugs Product Offerings
    Table 86. GSK Recent Development
    Table 87. Otsuka Pharmaceutical Company Information
    Table 88. Otsuka Pharmaceutical Introduction and Business Overview
    Table 89. Otsuka Pharmaceutical Genito-Urinary Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 90. Otsuka Pharmaceutical Genito-Urinary Drugs Product Offerings
    Table 91. Otsuka Pharmaceutical Recent Development
    Table 92. Sanofi Company Information
    Table 93. Sanofi Introduction and Business Overview
    Table 94. Sanofi Genito-Urinary Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 95. Sanofi Genito-Urinary Drugs Product Offerings
    Table 96. Sanofi Recent Development
    Table 97. Key Raw Materials Lists
    Table 98. Raw Materials Key Suppliers Lists
    Table 99. Genito-Urinary Drugs Downstream Customers
    Table 100. Genito-Urinary Drugs Distributors List
    Table 101. Research Programs/Design for This Report
    Table 102. Key Data Information from Secondary Sources
    Table 103. Key Data Information from Primary Sources
List of Figures
    Figure 1. Genito-Urinary Drugs Product Picture
    Figure 2. Global Genito-Urinary Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Genito-Urinary Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Genito-Urinary Drugs Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Genito-Urinary Drugs Sales Price (2019-2030) & (USD/Unit)
    Figure 6. Genito-Urinary Drugs Report Years Considered
    Figure 7. Global Genito-Urinary Drugs Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Genito-Urinary Drugs Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Genito-Urinary Drugs Revenue in 2023
    Figure 10. Genito-Urinary Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. OTC Picture
    Figure 12. Rx Drugs Picture
    Figure 13. Global Genito-Urinary Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Genito-Urinary Drugs Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Genito-Urinary Drugs Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 16. Global Genito-Urinary Drugs Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Genito-Urinary Drugs Price by Type (2019-2030) & (USD/Unit)
    Figure 18. Product Picture of Hospital
    Figure 19. Product Picture of Drugs Store
    Figure 20. Product Picture of Other
    Figure 21. Global Genito-Urinary Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 22. Global Genito-Urinary Drugs Sales Value Market Share by Application, 2023 & 2030
    Figure 23. Global Genito-Urinary Drugs Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 24. Global Genito-Urinary Drugs Sales Volume Market Share by Application, 2023 & 2030
    Figure 25. Global Genito-Urinary Drugs Price by Application (2019-2030) & (USD/Unit)
    Figure 26. North America Genito-Urinary Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 27. North America Genito-Urinary Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 28. Europe Genito-Urinary Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 29. Europe Genito-Urinary Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 30. Asia Pacific Genito-Urinary Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 31. Asia Pacific Genito-Urinary Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 32. South America Genito-Urinary Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 33. South America Genito-Urinary Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 34. Middle East & Africa Genito-Urinary Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 35. Middle East & Africa Genito-Urinary Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 36. Key Countries/Regions Genito-Urinary Drugs Sales Value (%), (2019-2030)
    Figure 37. Key Countries/Regions Genito-Urinary Drugs Sales Volume (%), (2019-2030)
    Figure 38. United States Genito-Urinary Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 39. United States Genito-Urinary Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 40. United States Genito-Urinary Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 41. Europe Genito-Urinary Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 42. Europe Genito-Urinary Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 43. Europe Genito-Urinary Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 44. China Genito-Urinary Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 45. China Genito-Urinary Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 46. China Genito-Urinary Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 47. Japan Genito-Urinary Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 48. Japan Genito-Urinary Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 49. Japan Genito-Urinary Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 50. South Korea Genito-Urinary Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 51. South Korea Genito-Urinary Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 52. South Korea Genito-Urinary Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 53. Southeast Asia Genito-Urinary Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 54. Southeast Asia Genito-Urinary Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 55. Southeast Asia Genito-Urinary Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 56. India Genito-Urinary Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 57. India Genito-Urinary Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 58. India Genito-Urinary Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 59. Genito-Urinary Drugs Industrial Chain
    Figure 60. Genito-Urinary Drugs Manufacturing Cost Structure
    Figure 61. Channels of Distribution (Direct Sales, and Distribution)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Treatment for Genito Urinary Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Urinary Tract Infection Medications Market Research Report 2024
Global Urinary System Antibiotics Market Research Report 2024
Global Urinary Tract Infection UTI Medications Market Research Report 2025
Global Urinary Antibacterial and Antiseptic Pharmaceutical Market Research Report 2024
Complicated Urinary Tract Infections Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Urinary Tract Infection UTI Market Research Report 2024
Global Urinary Tract Infection Testing Market Research Report 2024
Global Norfloxacin Tablets Market Research Report 2025
Home Diagnostics for Urinary Tract Infection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Urinary Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Urinary Tract Infection Therapeutics Market Research Report 2025
Urinary System Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Lomefloxacin Market Research Report 2024
Global Urinary Tract Cancer Treatment Market Research Report 2024
Urinary Incontinence Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Systemic Fluoroquinolones Market Research Report 2025
Urological Medications Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Genitourinary System Treatment Market Research Report 2024
Genitourinary Cancers Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions